Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNKS2 | Q9H2K2 | 10/20 | 0.81 |
| ▸ | TNKS | O95271 | 9/20 | 0.81 |
| ▸ | PARP1 | P09874 | 5/20 | 0.81 |
| ▸ | HPGD | P15428 | 4/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.71 |
| ▸ | MAPT | P10636 | 1/20 | 0.71 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.71 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.71 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.71 |
| ▸ | GUSB | P08236 | 6/20 | 0.69 |
| ▸ | PARP2 | Q9UGN5 | 2/20 | 0.69 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.69 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.69 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.69 |
| ▸ | NPC1 | O15118 | 1/20 | 0.69 |
| ▸ | LMNA | P02545 | 1/20 | 0.69 |
| ▸ | GAA | P10253 | 1/20 | 0.69 |
| ▸ | HTT | P42858 | 1/20 | 0.69 |
| ▸ | RAB9A | P51151 | 1/20 | 0.69 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29592833 | 0.90 | TNKS (1.00) | TNKS2TNKSPARP1HPGDALDH1A1 | |
| SCHEMBL258433 | 0.90 | TNKS (1.00) | TNKS2TNKSPARP1HPGDALDH1A1 | |
| SCHEMBL6885282 | 0.90 | TNKS (0.93) | TNKS2TNKSPARP1HPGDALDH1A1 | |
| Hydrochloric Acid SCHEMBL31529601 | 0.88 | TNKS (0.96) | TNKS2TNKSPARP1HPGDALDH1A1 | |
| SCHEMBL12758425 | 0.87 | ALDH1A1 (0.73) | TNKS2TNKSPARP1HPGDALDH1A1 | |
| SCHEMBL6124189 | 0.87 | TNKS (0.93) | TNKS2TNKSPARP1HPGDALDH1A1 | |
| SCHEMBL6695755 | 0.86 | TNKS2 (0.63) | TNKS2TNKSPARP1HPGDALDH1A1 | |
| SCHEMBL12351809 | 0.85 | HPGD (0.69) | TNKS2TNKSPARP1HPGDALDH1A1 | |
| SCHEMBL8620410 | 0.85 | TNKS (0.83) | TNKS2TNKSPARP1HPGDALDH1A1 | |
| SCHEMBL10699127 | 0.85 | TNKS (0.61) | TNKS2TNKSPARP1HPGDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040219390-A1 | Benzoxazinone and quinazolinone derivatives | HONEYWELL INTERNATIONAL, INC. (US) | 2004-11-04 | — | — | US | claimed |
| WO-2004066315-A2 | BENZOXAZINONE AND QUINAZOLINONE DERIVATIVES | HONEYWELL INTERNATIONAL INC. (US) | 2004-08-05 | — | — | WO | claimed |
| WO-2004059604-A2 | METHOD AND SYSTEM FOR FABRICATING AN OLED | HONEYWELL INTERNATIONAL, INC. (US) | 2004-07-15 | — | — | WO | claimed |
| US-20040132228-A1 | Method and system for fabricating an OLED | HONEYWELL INTERNATIONAL INC. (US) | 2004-07-08 | — | — | US | claimed |
| US-20040219390-A1 | Benzoxazinone and quinazolinone derivatives | HONEYWELL INTERNATIONAL, INC. (US) | 2004-11-04 | — | — | US | disclosed |
| WO-2004066315-A2 | BENZOXAZINONE AND QUINAZOLINONE DERIVATIVES | HONEYWELL INTERNATIONAL INC. (US) | 2004-08-05 | — | — | WO | disclosed |
| US-20040132228-A1 | Method and system for fabricating an OLED | HONEYWELL INTERNATIONAL INC. (US) | 2004-07-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040219390-A1 | Benzoxazinone and quinazolinone derivatives | XDH, AOX1, CYP4X1 | TNKS2 976/4885TNKS 547/4885PARP1 466/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.